Dr. Sandra Fryhofer on the new mix-and-match booster strategy | COVID-19 Update for Oct. 26, 2021

AMA CXO Todd Unger discusses what physicians need to know about boosters for Moderna, J&J recipients, and the newly approved mix-and-match strategy, with Dr. Sandra Fryhofer, AMA’s liaison to the Advisory Committee on Immunization Practices (ACIP), and a member of ACIP’s COVID-19 Vaccine Workgroup.
0:00 AMA COVID-19 Update for October 26, 2021
0:47 Who needs a Moderna booster and when?
1:51 What is the booster timeframe for Johnson & Johnson’s Janssen vaccine?
2:40 Regarding mix-and-match strategy-are there recommendations on which vaccine people should get as a booster?
3:34 Share details from NIH study from NIAID "Mix and Match study"
6:11 What about side effects after booster shots?
6:44 Highlight considerations physicians should keep in mind when deciding which booster to give their patients
8:29 Discuss the science behind overall waning immunity and the Delta variant's role regarding booster shots
11:01 Is J&J Janssen now considered a two-dose vaccine?
11:46 Clarify how many COVID vaccine doses a person can receive
13:21 How will the “mix-and-match strategy” help our overall vaccine efforts?
14: 28 Do we expect the FDA and CDC to eventually expand eligibility to younger Americans who are not at high risk?
15:00 Vaccinations save lives and all three COVID-19 vaccines can be co-administered with others, like your flu shot
Stay up to date on the latest information about the pandemic: ama-assn.org/c....
Visit the COVID-19 Daily Video Updates page for more videos in this series: ama-assn.org/c....